NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
3.500
0.00 (0.00%)
Mar 9, 2026, 3:17 PM EDT - Market open
NovaBridge Biosciences Employees
NovaBridge Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 188 or -85.45% compared to the previous year.
Employees
32
Change (1Y)
-188
Growth (1Y)
-85.45%
Revenue / Employee
n/a
Profits / Employee
-$822,688
Market Cap
403.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Sutro Biopharma | 178 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 104 |
| PepGen | 57 |
| PureTech Health | 56 |
| DiaMedica Therapeutics | 28 |
| Benitec Biopharma | 19 |
NBP News
- 4 hours ago - Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease - Benzinga
- 8 hours ago - NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study - GlobeNewsWire
- 6 days ago - NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 - GlobeNewsWire
- 7 days ago - NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 18 days ago - NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform - GlobeNewsWire
- 19 days ago - NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer - GlobeNewsWire
- 6 weeks ago - NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei - GlobeNewsWire
- 2 months ago - NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer - GlobeNewsWire